Choi S, Kim BK, Yon DK, et al., 2023, Global Burden of Primary Liver Cancer and its Association with Underlying Aetiologies, Sociodemographic Status, and Sex Differences from 1990–2019: A DALY-Based Analysis of the Global Burden of Disease 2019 Study. Hepatology, 29(2): 433.

Ahn KS, Kang KJ, Hepatology M, 2019, Appropriate Treatment Modality for Solitary Small Hepatocellular Carcinoma: Radiofrequency Ablation vs. Resection vs. Transplantation? Journal of Clinical and Experimental Hepatology, 25(4): 354.

Katai H, Ishikawa T, Akazawa K, et al., 2018, Five-Year Survival Analysis of Surgically Resected Gastric Cancer Cases in Japan: A Retrospective Analysis of More Than 100,000 Patients from the Nationwide Registry of the Japanese Gastric Cancer Association (2001–2007). Gastric Cancer, 21: 144–154.

Waks AG, Winer EP, 2019, Breast Cancer Treatment: A Review. Journal of the American Medical Association, 321(3): 288–300.

Das V, Bhattacharya S, Chikkaputtaiah C, et al., 2019, The Basics of Epithelial-Mesenchymal Transition (EMT): A Study from a Structure, Dynamics, and Functional Perspective. Journal of Cellular Physiology, 234(9): 14535–14555.

Yousaf A, Tasneem N, Mustafa A, et al., 2021, Gastric Cancer Associated Risk Factors and Prevalence in Pakistan. Journal of Cancer Research and Therapeutics, 1(2): 73–78.

Moon AM, Singal AG, Tapper EB, et al., 2020, Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clinical Gastroenterology and Hepatology, 18(12): 2650–2666.

Asrani SK, Devarbhavi H, Eaton J, et al., 2019, Burden of Liver Diseases in the World. Journal of Hepatology, 70(1): 151–171.

Durand F, Levitsky J, Cauchy F, et al., 2019, Age and Liver Transplantation. Journal of Hepatology, 70(4): 745–758.

Liu R, Rizzo S, Whipple S, et al., 2021, Evaluating Eligibility Criteria of Oncology Trials Using Real-World Data and AI. Nature, 592(7855): 629–633.

Maryam S, Rasheed M, Javed I, et al., 2021, Synthesis and Function of Multi-Modality Probe for Early Tumor Diagnosis in Mouse. Asian Journal of Medical Sciences, 152–162.

Filgueira NA, 2019, Hepatocellular Carcinoma Recurrence After Liver Transplantation: Risk Factors, Screening and Clinical Presentation. World Journal of Hepatology, 11(3): 261.

Mamone G, Caruso S, Milazzo M, et al., 2023, Imaging of Hepatocellular Carcinoma Recurrence After Liver Transplantation. Insights in Imaging, 14(1): 84.

Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D, 2021, Hepatocellular Carcinoma (HCC): Epidemiology, Etiology and Molecular Classification. Advances in Cancer Research, 149: 1–61.

Lin YL, Li Y, 2020, Study on the Hepatocellular Carcinoma Model with Metastasis. Gastrointestinal Diseases, 7(3): 336–350.

Dujon AM, Capp JP, Brown JS, et al., 2021, Is There One Key Step in the Metastatic Cascade? Cancer, 13(15): 3693.

Popper H, 2020, Primary Tumor and Metastasis—Sectioning the Different Steps of the Metastatic Cascade. Translational Lung Cancer Research, 9(5): 2277.

Sökeland G, Schumacher U, 2019, The Functional Role of Integrins During Intra- and Extravasation Within the Metastatic Cascade. Molecular Cancer, 18(1): 12.

Chernosky NM, Tamagno I, 2021, The Role of the Innate Immune System in Cancer Dormancy and Relapse. Cancers, 13(22): 5621.

Menzel L, Höpken UE, Rehm A, 2020, Angiogenesis in Lymph Nodes is a Critical Regulator of Immune Response and Lymphoma Growth. Frontiers in Immunology, 11: 591741.

Fares J, Fares MY, Khachfe HH, et al., 2020, Molecular Principles of Metastasis: A Hallmark of Cancer Revisited. Signal Transduction and Therapy, 5(1): 28.

Massague J, Ganesh K, 2021, Metastasis-Initiating Cells and Ecosystems. Cancer Discovery, 11(4): 971–994.

Truman JW, 2019, The Evolution of Insect Metamorphosis. Current Biology, 29(23): R1252–R1268.

Bergers G, Fendt SM, 2021, The Metabolism of Cancer Cells During Metastasis. Nature Reviews Cancer, 21(3): 162–180.

Liang L, Kaufmann AM, 2023, The Significance of Cancer Stem Cells and Epithelial-Mesenchymal Transition in Metastasis and Anti-Cancer Therapy. International Journal of Molecular Sciences, 24(3): 2555.

Aramini B, Masciale V, Arienti C, et al., 2022, Cancer Stem Cells (CSCs), Circulating Tumor Cells (CTCs) and Their Interplay with Cancer-Associated Fibroblasts (CAFs): A New World of Targets and Treatments. Cancers, 14(10): 2408.

Lee TK-W, Guan X-Y, Ma S, 2022, Cancer Stem Cells in Hepatocellular Carcinoma—From Origin to Clinical Implications. Nature Reviews Gastroenterology and Hepatology, 19(1): 26–44.

Qing X, Xu W, Zong J, et al., 2021, Emerging Treatment Modalities for Systemic Therapy in Hepatocellular Carcinoma. Biomedicine Research International, 9(1): 64.

Ullah MW, Manan S, Khattak WA, et al., 2020, Biotemplate-Mediated Green Synthesis and Applications of Nanomaterials. Current Pharmaceutical Design, 26(45): 5819–5836.

Lim JR, Mouawad J, Gorton OK, et al., 2021, Cancer Stem Cell Characteristics and Their Potential as Therapeutic Targets. Medical Oncology, 38(7): 76.

Ho DWH, Tsui YM, Sze KMF, et al., 2019, Single-Cell Transcriptomics Reveals the Landscape of Intra-Tumoral Heterogeneity and Stemness-Related Subpopulations in Liver Cancer. Cell, 459: 176–185.

Alqahtani A, Khan Z, Alloghbi A, et al., 2019, Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicine, 55(9): 526.

Zarębska I, Gzil A, Durślewicz J, et al., 2021, The Clinical, Prognostic and Therapeutic Significance of Liver Cancer Stem Cells and Their Markers. Gastroenterology, 45(3): 101664.

Ahn JC, Teng PC, Chen PJ, et al., 2021, Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma. Hepatology, 73(1): 422–436.

Ribatti D, Tamma R, Annese T, 2020, Epithelial-Mesenchymal Transition in Cancer: A Historical Overview. Translational Oncology, 13(6): 100773.

Lv J, Chen FK, Liu C, et al., 2020, Zoledronic Acid Inhibits Thyroid Cancer Stemness and Metastasis by Repressing M2-Like Tumor-Associated Macrophages Induced Wnt/β-Catenin Pathway. Life Sciences, 256: 117925.

Gaponova A, Rodin S, Mazina A, et al., 2020, Epithelial-Mesenchymal Transition: Role in Cancer Progression and the Perspectives of Antitumor Treatment. Advances in Nanoscience, 12(3(46)): 4–23.

Papadaki MA, Stoupis G, Theodoropoulos PA, et al., 2019, Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer. Molecular Cancer Therapeutics, 18(2): 437–447.

Li B, Cao Y, Meng G, et al., 2019, Targeting Glutaminase 1 Attenuates Stemness Properties in Hepatocellular Carcinoma by Increasing Reactive Oxygen Species and Suppressing Wnt/β-Catenin Pathway. Experimental Cell Research, 39: 239–254.

Devan AR, Pavithran K, Nair B, et al., 2022, Deciphering the Role of Transforming Growth Factor-Beta 1 as a Diagnostic-Prognostic-Therapeutic Candidate Against Hepatocellular Carcinoma. World Journal of Gastroenterology, 28(36): 5250.

Imodoye SO, Adedokun KA, Muhammed AO, et al., 2021, Understanding the Complex Milieu of Epithelial-Mesenchymal Transition in Cancer Metastasis: New Insight into the Roles of Transcription Factors. Frontiers in Oncology, 11: 762817.

Hajizadeh F, Okoye I, Esmaily M, et al., 2019, Hypoxia Inducible Factors in the Tumor Microenvironment as Therapeutic Targets of Cancer Stem Cells. Life Sciences, 237: 116952.

Papadakos SP, Arvanitakis K, Stergiou IE, et al., 2023, The Role of TLR4 in the Immunotherapy of Hepatocellular Carcinoma: Can We Teach an Old Dog New Tricks? Cancers, 15(10): 2795.

Tripathi S, Levine H, Jolly MK, 2020, The Physics of Cellular Decision Making During Epithelial-Mesenchymal Transition. Annual Review of Biophysics, 49: 1–18.

Wan S, Kim TH, Smith KJ, et al., 2019, New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma. Scientific Reports, 9(1): 18575.

Roshan MK, Soltani A, Soleimani A, et al., 2019, Role of AKT and mTOR Signaling Pathways in the Induction of Epithelial-Mesenchymal Transition (EMT) Process. Biomedicine & Pharmacotherapy, 165: 229–234.

Orrapin S, Udomruk S, Lapisatepun W, et al., 2022, Clinical Implication of Circulating Tumor Cells Expressing Epithelial Mesenchymal Transition (EMT) and Cancer Stem Cell (CSC) Markers and Their Perspective in HCC: A Systematic Review. Cancers, 14(14): 3373.

Wu Q, Zhou L, Lv D, et al., 2019, Exosome-Mediated Communication in the Tumor Microenvironment Contributes to Hepatocellular Carcinoma Development and Progression. Journal of Hepatology and Oncology, 12: 1–11.

Chen C, Wang Z, Ding Y, et al., 2023, Tumor Microenvironment-Mediated Immune Evasion in Hepatocellular Carcinoma. Frontiers in Immunology, 14: 1133308.

Walker C, Mojares E, del Río Hernández A, 2018, Role of Extracellular Matrix in Development and Cancer Progression. International Journal of Molecular Sciences, 19(10): 3028.

Cirri P, Chiarugi P, 2012, Cancer-Associated-Fibroblasts and Tumour Cells: A Diabolic Liaison Driving Cancer Progression. Cancer & Metabolism Reviews, 31: 195–208.

Kuppa SS, Kim HK, Kang JY, et al., 2022, Role of Mesenchymal Stem Cells and Their Paracrine Mediators in Macrophage Polarization: An Approach to Reduce Inflammation in Osteoarthritis. International Journal of Molecular Sciences, 23(21): 13016.

Fang X, Yan Q, Liu S, et al., 2022, Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation. International Journal of Molecular Sciences, 23(20): 12327.

Mitra A, Yan J, Xia X, et al., 2017, IL6‐Mediated Inflammatory Loop Reprograms Normal to Epithelial‐Mesenchymal Transition+ Metastatic Cancer Stem Cells in Preneoplastic Liver of Transforming Growth Factor Beta–Deficient β2‐Spectrin+/− Mice. Hepatology, 65(4): 1222–1236.

Ghotra VP, Puigvert JC, Danen EH, 2009, The Cancer Stem Cell Microenvironment and Anti-Cancer Therapy. International Journal of Radiation Biology, 85(11): 955–962.

Najafi M, Farhood B, Mortezaee K, 2019, Cancer Stem Cells (CSCs) in Cancer Progression and Therapy. Journal of Cellular Physiology, 234(6): 8381–8395.

Liu Y, Cao X, 2016, Characteristics and Significance of the Pre-Metastatic Niche. Cancer Cell, 30(5): 668–681.

Wang D, Li Y, Ge H, et al., 2022, The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Cancers, 14(16): 3998.

Wilson GK, Tennant DA, McKeating JA, 2014, Hypoxia Inducible Factors in Liver Disease and Hepatocellular Carcinoma: Current Understanding and Future Directions. Journal of Hepatology, 61(6): 1397–1406.

Tsui YM, Chan LK, Ng IOL, 2020, Cancer Stemness in Hepatocellular Carcinoma: Mechanisms and Translational Potential. British Journal of Cancer, 122(10): 1428–1440.

Muz B, de la Puente P, Azab F, et al., 2015, The Role of Hypoxia in Cancer Progression, Angiogenesis, Metastasis, and Resistance to Therapy, Hematology, 83–92.

Sultan H, 2021, Protein and Polysaccharide Base Biomaterial for the Formation of Composite Bone Scaffold, American Journal of Medical Sciences, 80–88.

Sainz JB, Carron E, Vallespinós M, et al., 2016, Cancer Stem Cells and Macrophages: Implications in Tumor Biology and Therapeutic Strategies, Mediators of Inflammation, 2016(1): 9012369.

Yamashita T, Wang XW, 2013, Cancer Stem Cells in the Development of Liver Cancer, The Journal of Clinical Investigation, 123(5): 1911–1918.

Aman MN, 2023, The Role of Extracellular Matrix in Tumor Progression and Treatment Response.

Wu Y, Zhang J, Zhang X, et al., 2020, Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy, Frontiers in Pharmacology, 11: 198.

Sajid T, Khan J, Abbas Z, et al., 2024, Targeting Cancers: Uncovering the Potential Roles of Potato Tissue Culture as Anti-Cancer Agents—A Secondary Publication, Proceedings of Annual Research, 8(3): 36–50.

He X, Lee B, Jiang Y, 2022, Extracellular Matrix in Cancer Progression and Therapy, Medical Research, 2(2): 125–139.

Riaz M, Zubair M, Iqbal MK, et al., 2024, Exploring the Platelet and Cancer Cell Interaction in Metastasis Targeting: Platelets and Cancer Cell Interaction, Journal of Clinical Oncology and Medical Sciences, 4(2): 834–844.

Sleeboom JJ, van Tienderen GS, Schenke-Layland K, et al., 2024, The Extracellular Matrix as Hallmark of Cancer and Metastasis: From Biomechanics to Therapeutic Targets, Science Translational Medicine, 16(728): eadg3840.

Tang ZY, Ye SL, Liu YK, et al., 2004, A Decade’s Studies on Metastasis of Hepatocellular Carcinoma, Chinese Journal of Oncology, 130: 187–196.

Wang S, Chen L, Liu W, 2022, Matrix Stiffness-Dependent STEAP3 Coordinated with PD-L2 Identify Tumor Responding to Sorafenib Treatment in Hepatocellular Carcinoma, Cancer Cell International, 22(1): 318.

Sun Y, Li H, Chen Q, et al., 2021, The Distribution of Liver Cancer Stem Cells Correlates with the Mechanical Heterogeneity of Liver Cancer Tissue, Hepatology and Cell Biology, 156: 47–58.

Lam KH, Ma S, 2023, Noncellular Components in the Liver Cancer Stem Cell Niche: Biology and Potential Clinical Implications, Hepatology, 78(3): 991–1005.

Lv D, Chen L, Du L, et al., 2021, Emerging Regulatory Mechanisms Involved in Liver Cancer Stem Cell Properties in Hepatocellular Carcinoma, Frontiers in Cell and Developmental Biology, 9: 691410.

Pantel K, Speicher M, 2016, The Biology of Circulating Tumor Cells, Oncology, 35(10): 1216–1224.

Lozar T, Gersak K, Cemazar M, et al., 2019, The Biology and Clinical Potential of Circulating Tumor Cells, Reproductive Oncology, 53(2): 131–147.

Van Dalum G, Holland L, Terstappen LW, 2012, Metastasis and Circulating Tumor Cells, European Oncology, 23(3): 87.

Niu Q, Ye S, Zhao L, et al., 2024, The Role of Liver Cancer Stem Cells in Hepatocellular Carcinoma Metastasis, Cancer Biology and Therapy, 25(1): 2321768.

Zhang Y, Li J, Cao L, et al., 2012, Circulating Tumor Cells in Hepatocellular Carcinoma: Detection Techniques, Clinical Implications, and Future Perspectives, Paper Presented at the Seminars in Oncology.

Espejo-Cruz ML, González-Rubio S, Zamora-Olaya J, et al., 2021, Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal. International Journal of Molecular Sciences, 22(23): 13073.

Sentoso JW, Putra A, Alif I, et al., 2024, Targeting Unique Features of Quiescent Cancer Stem Cells to Overcome Resistance and Recurrence in Cancer Therapy: A Review. Journal of Cancer International, 14(1): 18–31.

Lei MML, Lee TKW, 2021, Cancer Stem Cells: Emerging Key Players in Immune Evasion of Cancers. Frontiers in Cell and Developmental Biology, 9: 692940.

De Angelis ML, Francescangeli F, Zeuner A, 2019, Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities. Cancers, 11(10): 1569.

Liu YC, Yeh CT, Lin KH, 2020, Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cancers, 9(6): 1331.

Amini P, Moazamiyanfar R, Dakkali MS, et al., 2023, Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review. Current Topics in Medicinal Chemistry, 23(8): 629–648.

Chen K, Zhang C, Ling S, et al., 2021, The Metabolic Flexibility of Quiescent CSC: Implications for Chemotherapy Resistance. Cellular and Molecular Life Sciences, 12(9): 835.

Wu Y, Hao X, Wei H, et al., 2023, Blockade of T‐cell Receptor with Ig and ITIM Domains Elicits Potent Antitumor Immunity in Naturally Occurring HBV‐related HCC in Mice. Hepatology, 77(3): 965–981.

Galassi C, Musella M, Manduca N, et al., 2021, The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure. Cancers, 10(9): 2361.

Sajid M, Liu L, Sun C, 2022, The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications. Frontiers in Immunology, 13: 887186.

Yang J, Antin P, Berx G, et al., 2020, Guidelines and Definitions for Research on Epithelial–Mesenchymal Transition. Nature Reviews Molecular Cell Biology, 21(6): 341–352.

Majumder S, McGeachy MJ, 2021, IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry. Annual Review of Immunology, 39: 537–556.

Shevyrev D, Tereshchenko V, 2020, Treg Heterogeneity, Function, and Homeostasis. Frontiers in Immunology, 10: 495736.

Faubert B, Solmonson A, DeBerardinis RJ, 2020, Metabolic Reprogramming and Cancer Progression. Science, 368(6487): eaaw5473.

Ahmed N, Escalona R, Leung D, et al., 2018, Tumour Microenvironment and Metabolic Plasticity in Cancer and Cancer Stem Cells: Perspectives on Metabolic and Immune Regulatory Signatures in Chemoresistant Ovarian Cancer Stem Cells. Seminars in Cancer Biology, 53: 265–281.

Gottlieb RA, Bernstein D, 2016, Mitochondrial Remodeling: Rearranging, Recycling, and Reprogramming. Cancer Cell, 60(2): 88–101.

Chang CW, Lo JF, Wang XW, 2019, Roles of Mitochondria in Liver Cancer Stem Cells. Development, 107: 35–41.

Liu J, Qin X, Pan D, et al., 2019, Amino Acid‐Mediated Metabolism: A New Power to Influence Properties of Stem Cells. Stem Cells International, 2019(1): 6919463.

Daniel Y, Lelou E, Aninat C, et al., 2021, Interplay Between Metabolism Reprogramming and Epithelial-to-Mesenchymal Transition in Cancer Stem Cells. Cancers, 13(8): 1973.

Zubair M, Sultan HM, ur Rahman B, et al., 2024, CRISPR-Cas9: A Promising Therapeutic Approach for Diabetes Mellitus. International Journal of General Practice and Nutrition, 2(2): 43–56.

Zhang Q, Li W, 2022, Correlation between Amino Acid Metabolism and Self-Renewal of Cancer Stem Cells: Perspectives in Cancer Therapy. World Journal of Stem Cells, 14(4): 267.

Jain RK, 2012, Delivery of Molecular and Cellular Medicine to Solid Tumors. Advanced Drug Delivery Reviews, 64: 353–365.

Hassan G, Seno M, 2020, Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments. Cancer, 9(5): 1293.

Nowicki A, Kulus M, Wieczorkiewicz M, et al., 2021, Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and Oncology. Cancers, 13(16): 4178.

Moore G, Annett S, McClements L, et al., 2020, Top Notch Targeting Strategies in Cancer: A Detailed Overview of Recent Insights and Current Perspectives. Cancers, 9(6): 1503.

Yang L, Shi P, Zhao G, et al., 2020, Targeting Cancer Stem Cell Pathways for Cancer Therapy. Therapy, 5(1): 8.

Becker AP, Sells BE, Haque SJ, et al., 2021, Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology. Cancers, 13(4): 761.

Dong C, Ma H, Mi N, et al., 2024, Integrated Analysis of scRNA-seq and Bulk RNA-seq Reveals That GPRC5A is an Important Prognostic Gene in Pancreatic Cancer and is Associated with B-Cell Infiltration in Pancreatic Cancer. Frontiers in Oncology, 14: 1283164.

Litvina E, Adams A, Barth A, et al., 2019, BRAIN Initiative: Cutting-Edge Tools and Resources for the Community. Journal of Neuroscience, 39(42): 8275–8284.

Januškevičienė I, Petrikaitė V, 2019, Heterogeneity of Breast Cancer: The Importance of Interaction Between Different Tumor Cell Populations. Life Sciences, 239: 117009.

Saviano A, Henderson NC, Baumert TF, 2020, Single-Cell Genomics and Spatial Transcriptomics: Discovery of Novel Cell States and Cellular Interactions in Liver Physiology and Disease Biology. Journal of Hepatology, 73(5): 1219–1230.

Lehmann R, Lee CM, Shugart EC, et al., 2019, Human Organoids: A New Dimension in Cell Biology. Molecular Biology of the Cell, 30(10): 1129–1137.

Ingber DE, 2022, Human Organs-on-Chips for Disease Modelling, Drug Development and Personalized Medicine. Nature Reviews Genetics, 23(8): 467–491.

Wood LD, Ewald AJ, 2021, Organoids in Cancer Research: A Review for Pathologist‐Scientists. The Journal of Pathology, 254(4): 395–404.

Neophytou CM, Panagi M, Stylianopoulos T, et al., 2021, The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities. Cancers, 13(9): 2053.

Bocci F, Gearhart-Serna L, Boareto M, et al., 2019, Toward Understanding Cancer Stem Cell Heterogeneity in the Tumor Microenvironment. Proceedings of the National Academy of Sciences, 116(1): 148–157.

Ahmed HMM, Nimmagadda SC, Al‐Matary YS, et al., 2022, Dexamethasone‐Mediated Inhibition of Notch Signalling Blocks the Interaction of Leukaemia and Mesenchymal Stromal Cells. British Journal of Haematology, 196(4): 995–1006.

Zhu X, Zhang B, He Y, et al., 2021, Liver Organoids: Formation Strategies and Biomedical Applications. Trends in Endocrinology and Metabolism, 18(4): 573–585.

Natale A, Vanmol K, Arslan A, et al., 2019, Technological Advancements for the Development of Stem Cell-Based Models for Hepatotoxicity Testing. Archives of Toxicology, 93: 1789–1805.

Nimmakayala RK, Batra SK, Ponnusamy MP, 2019, Unraveling the Journey of Cancer Stem Cells from Origin to Metastasis. Biochimica et Biophysica Acta - Reviews on Cancer, 1871(1): 50–63.

Nussinov R, Tsai CJ, Jang H, 2021, Anticancer Drug Resistance: An Update and Perspective. Drug Resistance Updates, 59: 100796.

Wang R, Li J, Zhou X, et al., 2022, Single-Cell Genomic and Transcriptomic Landscapes of Primary and Metastatic Colorectal Cancer Tumors. Genomic Medicine, 14(1): 93.

Chowdhury S, Hofree M, Lin K, et al., 2021, Implications of Intratumor Heterogeneity on Consensus Molecular Subtype (CMS) in Colorectal Cancer. Cancers, 13(19): 4923.

Wang Y, Leaker B, Qiao G, et al., 2023, Precision-Cut Liver Slices as an Ex Vivo Model to Evaluate Antifibrotic Therapies for Liver Fibrosis and Cirrhosis. Biology, 8(11): e0558.

Pearen MA, Lim HK, Gratte FD, et al., 2020, Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology. Journal, (157): e60992.

Zakrzewski W, Dobrzyński M, Szymonowicz M, et al., 2019, Stem Cells: Past, Present, and Future. Stem Cell Research & Therapy, 10(1): 1–22.

Caruso S, O’Brien DR, Cleary SP, et al., 2021, Genetics of Hepatocellular Carcinoma: Approaches to Explore Molecular Diversity. Hepatology, 73: 14–26.

Jiang J, Pieterman CD, Ertaylan G, et al., 2019, The Application of Omics-Based Human Liver Platforms for Investigating the Mechanism of Drug-Induced Hepatotoxicity In Vitro. Applied Toxicology, 93: 3067–3098.

Odagiri N, Matsubara T, Sato-Matsubara M, et al., 2021, Anti-Fibrotic Treatments for Chronic Liver Diseases: The Present and the Future. Cancer & Hepatology, 27(3): 413.

Ruman U, Fakurazi S, Masarudin MJ, et al., 2020, Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities. International Journal of Nanomedicine, 1437–1456.

Menyailo ME, Tretyakova MS, Denisov EV, 2020, Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds. International Journal of Molecular Sciences, 21(5): 1696.

Tilsed C, 2021, How Does Chemotherapy Cure? Exploring and Exploiting the Immune System to Transform the Tumor Microenvironment and Improve Chemotherapy Efficacy, thesis, University of Western Australia.

Lone SN, Nisar S, Masoodi T, et al., 2022, Liquid Biopsy: A Step Closer to Transform Diagnosis, Prognosis, and Future of Cancer Treatments. Molecular Cancer, 21(1): 79.

Habli Z, AlChamaa W, Saab R, et al., 2020, Circulating Tumor Cell Detection Technologies and Clinical Utility: Challenges and Opportunities. Cancers, 12(7): 1930.

Stejskal P, Goodarzi H, Srovnal J, et al., 2023, Circulating Tumor Nucleic Acids: Biology, Release Mechanisms, and Clinical Relevance. Molecular Cancer, 22(1): 15.

Ribeiro IP, de Melo JB, Carreira IM, 2019, Head and Neck Cancer: Searching for Genomic and Epigenetic Biomarkers in Body Fluids–the State of Art. Molecular Cancer, 12(1): 33.

Chen WH, Luo GF, Zhang XZ, 2019, Recent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials. Advanced Materials, 31(3): 1802725.

Castro-Giner F, Aceto N, 2020, Tracking Cancer Progression: From Circulating Tumor Cells to Metastasis. Genomic Medicine, 12(1): 31.

Compton C, Compton C, 2020, Cancer Initiation, Promotion, and Progression and the Acquisition of Key Behavioral Traits. Cancer: The Enemy from Within, Springer, Amsterdam, 25–48.

Lin D, Shen L, Luo M, et al., 2021, Circulating Tumor Cells: Biology and Clinical Significance. Therapy, 6(1): 404.

Słomka A, Wang B, Mocan T, et al., 2022, Extracellular Vesicles and Circulating Tumor Cells–Complementary Liquid Biopsies or Standalone Concepts? Therapy, 12(13): 5836.

Sayed ZS, Khattap MG, Madkour MA, et al., 2024, Circulating Tumor Cells Clusters and Their Role in Breast Cancer Metastasis: A Review of Literature. Diagnostic Oncology, 15(1): 94.

Chen F, Zhong Z, Tan H-Y, et al., 2020, The Significance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma: Real-Time Monitoring and Moving Targets for Cancer Therapy. Cancers, 12(7): 1734.

Zhou J, Zhang Z, Zhou H, et al., 2020, Preoperative Circulating Tumor Cells to Predict Microvascular Invasion and Dynamical Detection Indicate the Prognosis of Hepatocellular Carcinoma. BioCell, 20: 1–10.

Zubair M, Riaz M, Kiani MN, et al., 2024, Application of Nanotechnology for Targeted Drug Delivery and Nontoxicity. International Journal of Green Pharmacy and Nanomedicine, 2(2): 57–67.